Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT01674374What this trial is testingBotanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapyWho this might be right forMucositisRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+29 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)WithdrawnNCT01465815What this trial is testingPhase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)Who this might be right forRecurrent Skin CancerRecurrent Squamous Cell Carcinoma of the Lip and Oral CavitySquamous Cell Carcinoma of the Skin+3 more OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Testing effectiveness (Phase 2)UnknownNCT00003257What this trial is testingGene Therapy in Treating Patients With Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Aventis Pharmaceuticals 39
Testing effectiveness (Phase 2)UnknownNCT00690872What this trial is testingGemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerWho this might be right forHead and Neck Cancer National Cancer Centre, Singapore 35
Early research (Phase 1)Study completedNCT00011778What this trial is testingPS-341 and Radiation to Treat Advanced Cancer of the Head and NeckWho this might be right forSquamous Cell Carcinoma National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT00021424What this trial is testingVaccine Therapy in Treating Patients With Stage IV Head and Neck CancerWho this might be right forHead and Neck CancerMetastatic Cancer National Institute on Deafness and Other Communication Disorders (NIDCD)
Not applicableStudy completedNCT00897273What this trial is testingOral HPV Infection in Young MenWho this might be right forHead and Neck CancerInfectionPrecancerous Condition Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 500
Large-scale testing (Phase 3)Study completedNCT02252042What this trial is testingPembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)Who this might be right forHead and Neck Squamous Cell Cancer Merck Sharp & Dohme LLC 495
Testing effectiveness (Phase 2)Ended earlyNCT04220775What this trial is testingBintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell CancerWho this might be right forRecurrent Head and Neck Squamous Cell CarcinomaSecond Primary Squamous Cell Carcinoma of the Head and Neck M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)UnknownNCT00589186What this trial is testingVaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal CancerWho this might be right forHead and Neck Cancer National Cancer Centre, Singapore 35
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205What this trial is testingA Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Who this might be right forUnresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer BioNTech SE 358
Testing effectiveness (Phase 2)Study completedNCT00005837What this trial is testingOxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerWho this might be right forCervical Cancer Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT01608022What this trial is testingA Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusWho this might be right forEsophageal Squamous Cell Carcinoma Yonsei University 48
Testing effectiveness (Phase 2)Study completedNCT01026792What this trial is testingTemsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By SurgeryWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more National Cancer Institute (NCI) 38
Early research (Phase 1)Looking for participantsNCT07545967What this trial is testingRe-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After RadiotherapyWho this might be right forHead and Neck Squamous Cell Carcinoma HNSCC West China Hospital 6
Large-scale testing (Phase 3)Study completedNCT00003592What this trial is testingMethotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 230
Testing effectiveness (Phase 2)Study completedNCT03274011What this trial is testingEfficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Neoplasms Fudan University 40
Large-scale testing (Phase 3)Looking for participantsNCT07264075What this trial is testingStudy Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHNWho this might be right forSquamous Cell Carcinoma Head and Neck Cancer (HNSCC) Groupe Oncologie Radiotherapie Tete et Cou 780